Formation of Research Management Committee Sample Clauses

Formation of Research Management Committee. The Research Program established by this Agreement shall be overseen by a Research Management Committee composed of an equal number of representatives from each Party (the "Research Management Committee") drawn from the ranks of senior scientists and senior research management of each Party. The total number of RMC members shall be agreed upon by the RMC from time to time. The Parties shall designate their representatives on the RMC within ten (10) days after the Effective Date. The Parties shall notify one another in writing of any change in the membership of the RMC as appropriate to allow for the participation of different research groups within Xxxxxxx and Xxxxx. The Parties shall agree upon the appropriate qualifications for members of the RMC and mechanisms for making substitutions for RMC members. An alternate member designated by a Party may serve temporarily in the absence of a permanent member of the RMC for such Party. Each Party shall designate one of its representatives as a co-chair of the RMC. Each co-chair of the RMC will be responsible for the agenda and the minutes of alternating RMC meetings.
Sample 1Sample 2Sample 3See All (4)
AutoNDA by SimpleDocs
Formation of Research Management Committee. The Research Collaboration shall be managed by the Research Management Committee comprised of an equal number of members appointed by each of Roche Bioscience and Tularik; provided that the size of the Research Management Committee shall not exceed a total of eight members. Either Party may appoint substitute or replacement members of the Research Management Committee to serve as their representatives. The initial members of the Research Management Committee shall be appointed by the Parties within 30 days following the Effective Date. The Research Management Committee shall have the responsibility and authority to: (a) plan and monitor the research; (b) assign tasks and responsibilities under the Research Plan to Tularik and Roche Bioscience; (c) review and modify the Research Plan as it shall deem appropriate to achieve the Parties' objectives of developing commercially successful Products; and (d) nominate Research Compounds for IND-enabling studies (and designate any such Research Compounds as either Roche Bioscience Compounds or Tularik Compounds prior to the commencement of such studies); provided that the Research Management Committee may not take any action in conflict with the express terms of this Agreement.
Sample 1Sample 2Sample 3
Formation of Research Management Committee. 10 3.2 Meetings of Research Management Committee................ 11 3.3 Decision-Making Process.................................. 11 4.
Sample 1Sample 2Sample 3
Formation of Research Management Committee. The Research will be managed by the Research Management Committee comprised of an equal number of members appointed by each of Roche Bioscience and Alanex; provided that the size of the Research Management Committee shall not exceed a total of eight members. Either Party may appoint substitute or replacement members of the Research Management Committee to serve as their representatives. The initial members of the Research Management Committee will be appointed by the Parties within 30 days following the Effective Date. The Research Management Committee shall have the responsibility and authority to: (a) plan and monitor the Research, (b) assign tasks and responsibilities under the Research Plan to Alanex and Roche Bioscience, respectively, subject to the terms and conditions of this Agreement which may not be amended except in accordance with Section 16.11 hereof (c) review and modify the Research Plan, as it shall deem appropriate to achieve the Parties' objectives under this Agreement, subject to the terms and conditions of this Agreement which may not be amended except in accordance with Section 16.11 hereof (d) review data related to Compounds to evaluate whether such Compounds satisfy the Preclinical Development Criteria, and (e) recommend Compounds to Roche Bioscience for selection as Lead Compounds. Notwithstanding the provisions of this Section 3.1, the Research Management Committee shall not have the authority to amend the Preclinical Development Criteria.
Sample 1

Related to Formation of Research Management Committee

  • Labour Management Committee (a) Where the parties mutually agree that there are matters of mutual concern and interest that would be beneficial if discussed at a Labour-Management Committee Meeting during the term of this Agreement, the following shall apply.

  • JOINT LABOUR MANAGEMENT COMMITTEE 18.01 A Joint Labour Management Committee shall be established to attend to those matters which are of mutual interest. To ensure its effectiveness the Committee shall be separate and apart from the grievance procedure.

  • Joint Development Committee The Parties shall form a joint development committee (the “Joint Development Committee” or “JDC”), made up of an equal number of representatives of Merck and BioLineRx, which shall have responsibility of coordinating all regulatory and other activities under, and pursuant to, this Agreement. Each Party shall designate a project manager (the “Project Manager”) who shall be responsible for implementing and coordinating activities, and facilitating the exchange of information between the Parties, with respect to the Study. Other JDC members will be agreed by both Parties. The JDC shall meet as soon as practicable after the Effective Date and then no less than twice yearly, and more often as reasonably considered necessary at the request of either Party, to provide an update on the progress of the Study. The JDC may meet in person or by means of teleconference, Internet conference, videoconference or other similar communications equipment. Prior to any such meeting, the BioLineRx Project Manager shall provide an update in writing to the Merck Project Manager, which update shall contain information about the overall progress of the Study, recruitment status, interim analysis (if results available), final analysis and other information relevant to the conduct of the Study. In addition to a Project Manager, each Party shall designate an alliance manager (the “Alliance Manager”), who shall endeavor to ensure clear and responsive communication between the Parties and the effective exchange of information, and shall serve as the primary point of contact for any issues arising under this Agreement. The Alliance Managers shall have the right to attend all JDC meetings and may bring to the attention of the JDC any matters or issues either of them reasonably believes should be discussed, and shall have such other responsibilities as the Parties may mutually agree in writing. In the event that an issue arises and the Alliance Managers cannot or do not, after good faith efforts, reach agreement on such issue, the issue shall be elevated to the Head of Clinical Oncology for Merck and the Vice President of Medical Affairs or Business Development for BioLineRx.

  • Development Committee As soon as practicable, the Parties will establish a joint development committee, comprised of up to [**] representatives of Verve and up to [**] representatives of Acuitas (the “JDC”). One such representative from each Party will be such Party’s Workplan Leader. Each Party may replace its Workplan Leader and other JDC representatives at any time upon written notice to the other Party, provided, however, that each Party shall use reasonable efforts to ensure continuity on the JDC. With the consent of the other Party (which will not be unreasonably withheld, conditioned or delayed), each Party may invite non-voting employees and consultants to attend JDC meetings, subject to their agreement to be bound to the same extent as a permitted subcontractor under Section 3.1(i).

  • Joint Union/Management Committee It shall be appropriate for either the Union or the University to request that a Joint Union/Management committee be convened, with Environmental Health and Safety as a participating member, to discuss health and safety concerns and to explore options for addressing those concerns through appropriate training or other approaches.

  • Joint Committee 1. The Contracting Parties shall establish a Joint Committee (hereinafter referred to as “the Committee”) with a view to accomplishing the objectives of this Agreement. The functions of the Committee shall be:

  • Local Professional Development Committee 1. The Local Professional Development Committee (LPDC) shall be established to oversee and review professional development plans pursuant to ORC 3319.22.

  • Professional Development Committee There shall be a Professional Development Committee composed of at least two (2) representatives of the Association and an equal number of representatives from the Hospital. Each party may have alternates to replace a member from time to time.

  • Operating Committee the Consortium’s managing body, composed of representatives of the Manager and the Contractors, pursuant to Annex XI.

  • The Joint Committee 1. A Joint Committee is hereby established in which each Contracting Party shall be represented.

Time is Money Join Law Insider Premium to draft better contracts faster.